Skip to main content

Advertisement

SpringerLink
Log in

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The 4th edition of the World Health Organization’s Classification of Head and Neck Tumours was published in January of 2017. This article provides a summary of the changes to Chapter 4 Tumours of the oral cavity and mobile tongue and Chapter 8 Odontogenic and maxillofacial bone tumours. Odontogenic cysts which were eliminated from the 3rd 2005 edition were included in the 4th edition as well as other unique allied conditons of the jaws. Many new tumors published since 2005 have been included in the 2017 classification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Koutlas IG, Allen CM, Warnock GR, Manivel JC. Sclerosing odontogenic carcinoma: a previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential. Am J Surg Pathol. 2008;39:1613–19.

    Article  Google Scholar 

  2. Irie T, Ogawa I, Takata T, Toyosawa S, Saito N, Akiba M, et al. Sclerosing odontogenic carcinoma with benign fibro-osseous lesion of the mandible: an extremely rare case report. Pathol Int. 2010;60:694–700.

    Article  PubMed  Google Scholar 

  3. Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, et al. Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinoma. Am J Surg Pathol. 2013;37:1001–5.

    Article  PubMed  Google Scholar 

  4. Yancoskie AE, Sreekantaiah C, Jacob J, Rosenberg A, Edelman M, Antonescu CR, et al. EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma: presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e115–e8.

    Article  PubMed  Google Scholar 

  5. Kunkel M, Ghalibafian M, Radner H, Reichert TE, Fischer B, Wanger W. Ameloblastic fibrosarcoma or odontogenic carcinosarcoma: a matter of classification. Oral Oncol. 2004;40:444–9.

    Article  PubMed  Google Scholar 

  6. Slater LJ. Odontogenic sarcoma and carcinosarcoma. Semin Diagn Pathol. 1999;16:325–32.

    CAS  PubMed  Google Scholar 

  7. DeLair D, Bejarano PA, Peleg M, El-Mofty SK. Ameloblastic carcinosarcoma of the mandible arising in ameloblastic fibroma: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:516–20.

    Article  PubMed  Google Scholar 

  8. Mosqueda-Taylor A, Neville BW, Tatemoto Y, Ogawa I, Takata T. Odontogenic carcinoma with dentinoid: a new odontogenic carcinoma. Head Neck Pathol. 2014;8:421–31.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kurppa KF, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232:492–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ, Zehnder JL, Beachy PA, Pollack JR, West RB. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46:722–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KS, Betz BL. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517–26.

    Article  CAS  PubMed  Google Scholar 

  12. Kumamoto H, Ohki K, Ooya K. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas. J Oral Pathol Med. 2004;33:185–90.

    Article  CAS  PubMed  Google Scholar 

  13. Dassule HR, Lewis P, Bei M, Maas R, McMahon AP. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development. 2000;127:4775–85.

    CAS  PubMed  Google Scholar 

  14. Heikinheimo K, Jee KJ, Niini T, Aalto Y, Happonen RP, Leivo I, Knuutila S. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res. 2002;81:525–30.

    Article  CAS  PubMed  Google Scholar 

  15. Pereira NB, Pereira KM, Coura BP, Diniz MG, de Castro WH, Gomes CC, Gomez RS. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. J Oral Pathol Med. 2016. doi:10.1111/jop.12443.

    Google Scholar 

  16. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.

    Article  CAS  PubMed  Google Scholar 

  17. Parada LF, Land H, Weinberg RA, Wolf D, Rotter V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature. 1984;312:649–51.

    Article  CAS  PubMed  Google Scholar 

  18. Li Y, Mangasarian K, Mansukhani A, Basilico C. Activation of FGF receptors by mutations in the transmembrane domain. Oncogene. 1997;14:1397–406.

    Article  CAS  PubMed  Google Scholar 

  19. Diniz MG, Gomes CC, Guimarães BV, Castro WH, Lacerda JC, Cardoso SV, de Faria PR, Dias FL, Eisenberg AL, Loyola AM, Gomez RS. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumour Biol. 2015;36:5649–53.

    Article  CAS  PubMed  Google Scholar 

  20. Brown NA, Betz BL. Ameloblastoma: a review of recent molecular pathogenetic discoveries. Biomark. Cancer. 2015;7(Suppl 2):19–24.

    Google Scholar 

  21. Kaye FJ, Ivey AM, Drane WE, Mendenhall WM, Allan RW. Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 2014;107:378.

    Article  PubMed  Google Scholar 

  22. Robinson L, Martinez MG. Unicystic ameloblastoma: a prognostically distinct entity. Cancer. 1977;40:2278–85.

    Article  CAS  PubMed  Google Scholar 

  23. Ackermann GL, Altini M, Shear M. The unicystic ameloblastoma: a clinicopathological study of 57 cases. J Oral Pathol. 1988;17:541–6.

    Article  CAS  PubMed  Google Scholar 

  24. Philipsen HP, Reichart PA. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol. 1998;34:317–25.

    Article  CAS  PubMed  Google Scholar 

  25. Li T-J, Wu Y-T, Yu S-F, Yu G-Y. Unicystic ameloblastoma. A clinicopathologic study of 33 Chinese patients. Am J Surg Pathol. 2000;10:1385–92.

    Article  Google Scholar 

  26. Vered M, Shohat I, Buchner A, Dayan D. Myofibroblasts in stroma of odontogenic cysts and tumors can contribute to variations in the biological behavior of lesions. Oral Oncol. 2005;41:1028–33.

    Article  PubMed  Google Scholar 

  27. Gu XM, Zhao HS, Sun LS, Li TJ. PTCH mutations in sporadic and Gorlin–syndrome-related odontogenic keratocysts. J Dent Res. 2006;85:859–63.

    Article  CAS  PubMed  Google Scholar 

  28. Li TJ, Yuan JW, Gu XM, Zhao HS. PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients. Oral Dis. 2008;25:174–9.

    Article  Google Scholar 

  29. Sun LS, Li XF, Li TJ. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J Dent Res. 2008;87:575–9.

    Article  CAS  PubMed  Google Scholar 

  30. Pan S, Li TJ. Mechanisms of inactivation of PTCH1 gene in keratocystic odontogenic tumors: modifivation of the two-hit hypothesis. Clin Cancer Res. 2010;16:442–50.

    Article  CAS  PubMed  Google Scholar 

  31. Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L. PTCH gene mutations in odontogenic keratocysts. J Dent Res. 2000;79:1418–22.

    Article  CAS  PubMed  Google Scholar 

  32. Ohki K, Kumamoto H, Ichinohasama R, Sato T, et al. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg. 2009;33:584–92.

    Article  Google Scholar 

  33. Song YL, Zhang WF, Peng B, Wang CN, et al. Germline mutations of the pTCH ggene in families with odontogenic keratocysts and nevoid basal cell carcinoma syndrome. Tumor Biol. 2006;27:175–80.

    Article  Google Scholar 

  34. Agaram NP, Collins B, Barnes L, Lomago D, et al. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med. 2004;128:313–7.

    CAS  PubMed  Google Scholar 

  35. Henley J, Summerlin D-J, Tomich C, Zhang S, Cheng L. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases. Histopathology. 2005;47:582–6.

    Article  CAS  PubMed  Google Scholar 

  36. Malcic´ A, Jukic´ S, Anic´ I, Pavelic´ B, et al. Alterations of FHIT and p53 genes in keratocystic odontogenic tumours, dentigerous cyst and radicular cyst. J Oral Pathol Med. 2008;37:294–301.

    Article  PubMed  Google Scholar 

  37. Pogrel MA, Jordan RC. Marsupialization as a definitive treatment for the odontogenic keratocyst. J Oral Maxillofac Surg. 2004;62:651–5.

    Article  PubMed  Google Scholar 

  38. Diniz MG, Galvao CF, Macedo PS, Gomes CC, Gomez RS. Evidence of loss of heterozygosity of the PTCH gene in orthokeratinized odontogenic cyst. J Oral Pathol Med. 2011;40:277–80.

    Article  CAS  PubMed  Google Scholar 

  39. Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517–26.

    Article  CAS  PubMed  Google Scholar 

  40. Galvão CF, Gomes CC, Diniz MG, Vargas PA, de Paula AM, Mosqueda-Taylor A, et al. Loss of heterozygosity (LOH) in tumour suppressor genes in benign and malignant mixed odontogenic tumours. J Oral Pathol Med. 2012;41:389–93.

    Article  PubMed  Google Scholar 

  41. Slootweg PJ. An analysis of the interrelationship of the mixed odontogenic tumors-ameloblastic fibroma, ameloblastic fibroodontoma, and the odontomas. Oral Surg Oral Med Oral Pathol. 1981;51:266–77.

    Article  CAS  PubMed  Google Scholar 

  42. Philipsen HP, Reichart PA, Praetorius F. Mixed odontogenic tumours and odontomas. Considerations on interrelationship. Review of the literature and presentation of 134 new cases of odontomas. Oral Oncol. 1997;33:86–99.

    Article  CAS  PubMed  Google Scholar 

  43. Buchner A, Vered M. Ameloblastic fibroma: a stage in the development of a hamartomatous odontoma or a true neoplasm? Critical analysis of 162 previously reported cases plus 10 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:598–606.

    Article  PubMed  Google Scholar 

  44. Ledesma-Montes C, Gorlin RJ, Shear M, Praetorius F, et al. International collaborative study on ghost cell odontogenic tumours: calcifying cystic odontogenic tumour, dentinogenic ghost cell tumour and ghost cell odontogenic carcinoma. J Oral Pathol Med. 2008;37:302–8.

    Article  PubMed  Google Scholar 

  45. Mosqueda-Taylor A, Pires FR, Aguirre- Urízar JM, Carlos-Bregni R, de la Piedra- Garza JM, Martínez-Conde R, et al. Primordial odontogenic tumour: clinicopathological analysis of six cases of a previously undescribed entity. Histopathology. 2014;65:606–12.

    Article  PubMed  Google Scholar 

  46. Slater LJ, Eftimie LF, Herford AS. Primordial odontogenic tumor: report of a case. J Oral Maxillofac Surg. 2016;74:547–51.

    Article  PubMed  Google Scholar 

  47. Bishop JA, Yonescu R, Batista D, Warnock GR, Westra WH. Glandular odontogenic cysts (GOCs) lack MAML2 rearrangements: a finding to discredit the putative nature of GOC as a precursor to central mucoepidermoid carcinoma. Head Neck Pathol. 2014;8:287–90.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Amary MF, Ye H, Forbes G, Damato S, Halai D, Berisha F, et al. Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas. Virchows Arch. 2015;466:217–22.

    Article  CAS  PubMed  Google Scholar 

  49. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51:127–39.

    Article  CAS  PubMed  Google Scholar 

  50. Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279–88.

    Article  CAS  PubMed  Google Scholar 

  51. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45:1479–82.

    Article  CAS  PubMed  Google Scholar 

  52. Flucke U, Tops BB, van Diest PJ, Slootweg PJ. Desmoid-type fibromatosis of the head and neck region in the paediatric population: a clinicopathologic and genetic study of seven cases. Hstopathology. 2014;64:769–76.

    Article  Google Scholar 

  53. E Horvai A, C Jordan R. Fibro-osseous lesions of the craniofacial bones; β –catenin immunohistochemical analysis and CT-NNB1 and APC mutation analysis. Head Neck. 2014;8:291–97.

    Article  Google Scholar 

  54. Marie PJ. Cellular and molecular basis of fibrous dysplasia. Histol Histopathol. 2001;16:981–8.

    CAS  PubMed  Google Scholar 

  55. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer. 1994;73:1411–24.

    Article  CAS  PubMed  Google Scholar 

  56. Romeo S, Hogendoorn PC, Dei Tos AP. Benign cartilaginous tumors of bone: from morphology to somatic and germline genetics. Adv Anat Pathol. 2009;16:307–15.

    Article  PubMed  Google Scholar 

  57. Presneau N, Baumhoer D, Behjati S, Pillay N, Tarpey P, Campbell P, et al. Diagnostic value of H3F3A mutations in giant cell tumor of bone compared to osteoclast-rich mimics. J Pathol. 2015;1:113–23.

    CAS  Google Scholar 

  58. Mangion J, Rahman N, Edkins S, Barfoot R, Nguyen T, Sigurdsson A, et al. The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet. 1999;65:151–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Sciences, Texas A&M University, School of Dentistry, 3302 Gaston Ave, Dallas, TX, 75246, USA

    John M. Wright

  2. Department of Oral Pathology and Oral Medicine, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel

    Marilena Vered

  3. Institute of Pathology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

    Marilena Vered

Authors
  1. John M. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marilena Vered
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Wright.

Ethics declarations

Conflict of interest

Neither Drs. Wright nor Vered have anything to disclose regarding potential conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

This article does not require Informed consent.

Additional information

Special Issue: World Health Organization Classification Update

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wright, J.M., Vered, M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head and Neck Pathol 11, 68–77 (2017). https://doi.org/10.1007/s12105-017-0794-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-017-0794-1

Keywords

Search

Navigation